Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 1/2018

01-10-2018

Mechanistic implication of decreased plasma atrial natriuretic peptide level for transient rise in the atrial capture threshold early after ICD or CRT-D implantation

Authors: Kojiro Ogawa, Kentaro Yoshida, Yoshiko Uehara, Mari Ebine, Akira Kimata, Hidetaka Nishina, Noriyuki Takeyasu, Yuichi Noguchi, Masaki Ieda, Kazutaka Aonuma, Akihiko Nogami

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2018

Login to get access

Abstract

Purpose

Despite the use of steroid-eluting leads, a transient but not persistent rise in the atrial/ventricular capture threshold (TRACT/TRVCT) can occur early after pacemaker implantation in patients with sick sinus syndrome. This study aimed to assess the prevalence, predictors, and mechanisms of TRACT/TRVCT in patients with heart failure undergoing implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) implantation.

Method

One hundred twenty consecutive patients underwent ICD (N = 70) or CRT (N = 50) implantation. Capture threshold was measured at implantation, 7-day, 1-month, and 6-month post-implantation. TRACT/TRVCT was defined as a threshold rise at 7 days by more than twice the height of the threshold at implantation, with full recovery during follow-up. Atrial and brain natriuretic peptide (ANP and BNP) levels were measured before implantation.

Results

TRACT and TRVCT were observed in 13 (11%) and 10 (8%) patients, respectively. Patients with TRACT had lower ANP level (median 72 [42–105] vs. 99 [49–198] pg/mL, P = 0.06), lower ANP/BNP ratio (0.29 [0.20–0.36] vs. 0.50 [0.33–0.70], P < 0.01), lower atrial sensing amplitude (2.0 ± 0.8 vs. 2.7 ± 1.3 mV, P = 0.02), and lower left ventricular ejection fraction (32 ± 12 vs. 40 ± 14%, P = 0.04) than those without TRACT. TRACT recovered within 1 month, whereas TRVCT recovered within 6 months. In multivariable analysis, ANP/BNP ratio was the only independent predictor of TRACT (OR, 0.018; 95% CI, 0.001–0.734; P = 0.034).

Conclusions

Atrial degenerative change characterized by lower ANP/BNP ratio was associated with the occurrence of TRACT in patients with heart failure. TRVCT could also occur, but it required a longer recovery time than TRACT.
Literature
1.
go back to reference Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728–35.CrossRefPubMed Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728–35.CrossRefPubMed
2.
go back to reference Mond HG, Helland JR, Stokes K, et al. The electrode-tissue interface: the revolutionary role of steroid-elution. Pacing Clin Electrophysiol. 2014;37:1232–49.CrossRefPubMed Mond HG, Helland JR, Stokes K, et al. The electrode-tissue interface: the revolutionary role of steroid-elution. Pacing Clin Electrophysiol. 2014;37:1232–49.CrossRefPubMed
3.
go back to reference Kimata A, Yoshida K, Takeyasu N, et al. Bradycardia-dependent rise in the atrial capture threshold early after cardiac pacemaker implantation in patients with sick sinus syndrome. HeartRhythm Case Rep. 2015;2:27–31.CrossRefPubMedPubMedCentral Kimata A, Yoshida K, Takeyasu N, et al. Bradycardia-dependent rise in the atrial capture threshold early after cardiac pacemaker implantation in patients with sick sinus syndrome. HeartRhythm Case Rep. 2015;2:27–31.CrossRefPubMedPubMedCentral
4.
go back to reference Uehara Y, Yoshida K, Kimata A, Ogawa K, Abe D, Tsumagari Y, et al. Underrecognized entity of the transient rise in the atrial capture threshold early after dual-chamber pacemaker implantation. Pacing Clin Electrophysiol. 2017;40:1396–404.CrossRefPubMed Uehara Y, Yoshida K, Kimata A, Ogawa K, Abe D, Tsumagari Y, et al. Underrecognized entity of the transient rise in the atrial capture threshold early after dual-chamber pacemaker implantation. Pacing Clin Electrophysiol. 2017;40:1396–404.CrossRefPubMed
5.
go back to reference Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al. BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA. 2009;301:383–92.CrossRefPubMed Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al. BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA. 2009;301:383–92.CrossRefPubMed
6.
go back to reference Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR. Amino-terminal pro-B-type natriuretic peptide for diagnosis and prognosis in patients with renal dysfunction: a systematic review and meta-analysis. JACC Heart Fail. 2015;3:977–89.CrossRefPubMedPubMedCentral Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR. Amino-terminal pro-B-type natriuretic peptide for diagnosis and prognosis in patients with renal dysfunction: a systematic review and meta-analysis. JACC Heart Fail. 2015;3:977–89.CrossRefPubMedPubMedCentral
7.
go back to reference van den Berg MP, van Gelder IC, van Veldhuisen DJ. Depletion of atrial natriuretic peptide during longstanding atrial fibrillation. Europace. 2004;6:433–7.CrossRefPubMed van den Berg MP, van Gelder IC, van Veldhuisen DJ. Depletion of atrial natriuretic peptide during longstanding atrial fibrillation. Europace. 2004;6:433–7.CrossRefPubMed
8.
go back to reference van den Berg MP, Tjeerdsma G, Jan de Kam P, et al. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur J Heart Fail. 2002;4:255–62.CrossRefPubMed van den Berg MP, Tjeerdsma G, Jan de Kam P, et al. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur J Heart Fail. 2002;4:255–62.CrossRefPubMed
9.
go back to reference Yoshihara F, Nishikimi T, Sasako Y, Hino J, Kobayashi J, Minatoya K, et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure. J Am Coll Cardiol. 2002;39:288–94.CrossRefPubMed Yoshihara F, Nishikimi T, Sasako Y, Hino J, Kobayashi J, Minatoya K, et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure. J Am Coll Cardiol. 2002;39:288–94.CrossRefPubMed
10.
go back to reference Yoshida K, Tada H, Ogata K, Sekiguchi Y, Inaba T, Ito Y, et al. Electrogram organization predicts left atrial reverse remodeling after the restoration of sinus rhythm by catheter ablation in patients with persistent atrial fibrillation. Heart Rhythm. 2012;9:1769–78.CrossRefPubMed Yoshida K, Tada H, Ogata K, Sekiguchi Y, Inaba T, Ito Y, et al. Electrogram organization predicts left atrial reverse remodeling after the restoration of sinus rhythm by catheter ablation in patients with persistent atrial fibrillation. Heart Rhythm. 2012;9:1769–78.CrossRefPubMed
11.
go back to reference Nakanishi K, Fukuda S, Yamashita H, Kosaka M, Shirai N, Tanaka A, et al. Pre-procedural serum atrial natriuretic peptide levels predict left atrial reverse remodeling after catheter ablation in patients with atrial fibrillation. JACC Clin Electrophysiol. 2016;2:151–8.CrossRefPubMed Nakanishi K, Fukuda S, Yamashita H, Kosaka M, Shirai N, Tanaka A, et al. Pre-procedural serum atrial natriuretic peptide levels predict left atrial reverse remodeling after catheter ablation in patients with atrial fibrillation. JACC Clin Electrophysiol. 2016;2:151–8.CrossRefPubMed
12.
go back to reference Fujita S, Shimojo N, Terasaki F, Otsuka K, Hosotani N, Kohda Y, et al. Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessel. 2013;28:646–57.CrossRef Fujita S, Shimojo N, Terasaki F, Otsuka K, Hosotani N, Kohda Y, et al. Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessel. 2013;28:646–57.CrossRef
13.
go back to reference Lee S, Wellens HJ, Josephson ME. Paroxysmal atrioventricular block. Heart Rhythm. 2009;6:1229–34.CrossRefPubMed Lee S, Wellens HJ, Josephson ME. Paroxysmal atrioventricular block. Heart Rhythm. 2009;6:1229–34.CrossRefPubMed
14.
go back to reference Davis LD. Effects of autonomic neurohumors on transmembrane potentials of atrial plateau fibers. Am J Phys. 1975;229:1351–6. Davis LD. Effects of autonomic neurohumors on transmembrane potentials of atrial plateau fibers. Am J Phys. 1975;229:1351–6.
15.
go back to reference Hasebe H, Yoshida K, Iida M, Hatano N, Muramatsu T, Nogami N, Aonuma K. Differences in the structural characteristics and distribution of epicardial adipose tissue between left and right atrial fibrillation. Europace. 2018;20:435–42. Hasebe H, Yoshida K, Iida M, Hatano N, Muramatsu T, Nogami N, Aonuma K. Differences in the structural characteristics and distribution of epicardial adipose tissue between left and right atrial fibrillation. Europace. 2018;20:435–42.
16.
go back to reference Yoshida K, Hattori A, Tsuneoka H, Tsumagari Y, Yui Y, Kimata A, et al. Electrophysiological relation between the superior vena cava and right superior pulmonary vein in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1117–26.CrossRefPubMed Yoshida K, Hattori A, Tsuneoka H, Tsumagari Y, Yui Y, Kimata A, et al. Electrophysiological relation between the superior vena cava and right superior pulmonary vein in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28:1117–26.CrossRefPubMed
17.
go back to reference Yoshida K, Yui Y, Kimata A, Koda N, Kato J, Baba M, et al. Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: relevance to AF substrate, procedural outcomes, and reverse structural remodeling. Heart Rhythm. 2014;11:1336–42.CrossRefPubMed Yoshida K, Yui Y, Kimata A, Koda N, Kato J, Baba M, et al. Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: relevance to AF substrate, procedural outcomes, and reverse structural remodeling. Heart Rhythm. 2014;11:1336–42.CrossRefPubMed
18.
go back to reference Luria DM, Feinberg MS, Gurevitz OT, et al. Randomized comparison of J-shaped atrial leads with and without active fixation mechanism. Pacing Clin Electrophysiol. 2007;30:412–7.CrossRefPubMed Luria DM, Feinberg MS, Gurevitz OT, et al. Randomized comparison of J-shaped atrial leads with and without active fixation mechanism. Pacing Clin Electrophysiol. 2007;30:412–7.CrossRefPubMed
Metadata
Title
Mechanistic implication of decreased plasma atrial natriuretic peptide level for transient rise in the atrial capture threshold early after ICD or CRT-D implantation
Authors
Kojiro Ogawa
Kentaro Yoshida
Yoshiko Uehara
Mari Ebine
Akira Kimata
Hidetaka Nishina
Noriyuki Takeyasu
Yuichi Noguchi
Masaki Ieda
Kazutaka Aonuma
Akihiko Nogami
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 1/2018
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0409-0

Other articles of this Issue 1/2018

Journal of Interventional Cardiac Electrophysiology 1/2018 Go to the issue